OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells
Maria Francesca Santolla, Marianna Talia, Francesca Cirillo, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2402-2402
Open Access | Times Cited: 13
Maria Francesca Santolla, Marianna Talia, Francesca Cirillo, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2402-2402
Open Access | Times Cited: 13
Showing 13 citing articles:
Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review
Mengzhou Zhou, Yuyan Zhang, Lin Shi, et al.
Pharmacological Research (2024) Vol. 206, pp. 107282-107282
Open Access | Times Cited: 32
Mengzhou Zhou, Yuyan Zhang, Lin Shi, et al.
Pharmacological Research (2024) Vol. 206, pp. 107282-107282
Open Access | Times Cited: 32
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
Veronica Vella, Rosamaria Lappano, Eduardo Bonavita, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 4, pp. 693-723
Open Access | Times Cited: 27
Veronica Vella, Rosamaria Lappano, Eduardo Bonavita, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 4, pp. 693-723
Open Access | Times Cited: 27
The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer
Jian Zheng, Hua Hao
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 15
Jian Zheng, Hua Hao
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 15
AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers
Gowri Palanissami, Solomon F.D. Paul
Exploration of Targeted Anti-tumor Therapy (2023), pp. 812-849
Open Access | Times Cited: 16
Gowri Palanissami, Solomon F.D. Paul
Exploration of Targeted Anti-tumor Therapy (2023), pp. 812-849
Open Access | Times Cited: 16
Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms
Yuyuan Zhang, Yongjiang Li, Chun-Dong Xue, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
Yuyuan Zhang, Yongjiang Li, Chun-Dong Xue, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
Implications of receptor for advanced glycation end products for progression from obesity to diabetes and from diabetes to cancer
Andrea Garza-Campos, José Roberto Prieto-Correa, José Alfredo Domı́nguez-Rosales, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 7, pp. 977-994
Open Access | Times Cited: 11
Andrea Garza-Campos, José Roberto Prieto-Correa, José Alfredo Domı́nguez-Rosales, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 7, pp. 977-994
Open Access | Times Cited: 11
RAGE and its ligands in breast cancer progression and metastasis
Madalina Coser, Bogdan Neamțu, Bogdan Pop, et al.
Oncology Reviews (2025) Vol. 18
Open Access
Madalina Coser, Bogdan Neamțu, Bogdan Pop, et al.
Oncology Reviews (2025) Vol. 18
Open Access
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells
Marianna Talia, Francesca Cirillo, Asia Spinelli, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 9
Marianna Talia, Francesca Cirillo, Asia Spinelli, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 9
A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression
Zhen Tang, Jing Hu, Xu-Chang Li, et al.
Developmental Cell (2024)
Closed Access | Times Cited: 1
Zhen Tang, Jing Hu, Xu-Chang Li, et al.
Developmental Cell (2024)
Closed Access | Times Cited: 1
Bioinformatic analysis and preliminary validation of potential therapeutic targets for COVID-19 infection in asthma patients
Yue Li, Ye Liu, Mengjie Duo, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Yue Li, Ye Liu, Mengjie Duo, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 6
KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker
Xiaoju Shen, Xiaocheng Mo, Weidan Tan, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 4
Xiaoju Shen, Xiaocheng Mo, Weidan Tan, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 4
Effect of AGEs-RAGE system on the efficacy of PD-1 inhibitors in the treatment of driver-gene mutation negative advanced non-squamous non-small cell lung cancer
Xiangying Li, Guan Wang, Xiuye Sun, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 14, pp. 155-160
Open Access | Times Cited: 1
Xiangying Li, Guan Wang, Xiuye Sun, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 14, pp. 155-160
Open Access | Times Cited: 1
Epigenetic Regulation in Breast Cancer Tumor Microenvironment
Bhavjot Kaur, Priya Mondal, Syed Musthapa Meeran
Epigenetics and human health (2023), pp. 213-243
Closed Access
Bhavjot Kaur, Priya Mondal, Syed Musthapa Meeran
Epigenetics and human health (2023), pp. 213-243
Closed Access
